References

Shetty K, Tuft H. Dental management of the pediatric post radiation therapy—rhabdomyosarcoma patient: case reports and review of literature. Oral Oncology Extra. 2005; 41:242-248
Dagher R, Helman L. Rhabdomyosarcoma: an overview. Oncologist. 1999; 4:34-44
Miloglu O, Altas SS, Buyukkurt MC Rhabdomyosarcoma of the oral cavity: a case report. Eur J Dent. 2011; 5:340-343
Kramer S, Meadows AT, Jarrett P, Evans AE. Incidence of childhood cancer: experience of a decade in a population-based registry. J Natl Cancer Inst. 1983; 70:49-55
Estilo CL, Huryn JM, Kraus DH Effects of therapy on dentofacial development in long-term survivors of head and neck rhabdomyosarcoma: the Memorial Sloan-Kettering cancer center experience. J Pediatr Hematol Oncol. 2003; 25:215-222 https://doi.org/10.1097/00043426-200303000-00007
Bras J, Batsakis JG, Luna MA. Rhabdomyosarcoma of the oral soft tissues. Oral Surg Oral Med Oral Pathol. 1987; 64:585-596 https://doi.org/10.1016/0030-4220(87)90065-x
Pap GS. Rhabdomyosarcoma: report of a case with involvement of the angle of the mandible. Int J Oral Surg. 1980; 9:491-493 https://doi.org/10.1016/s0300-9785(80)80083-4
Chen SY, Thakur A, Miller AS, Harwick RD. Rhabdomyosarcoma of the oral cavity. Report of four cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995; 80:192-201 https://doi.org/10.1016/s1079-2104(05)80202-1
Malkin D, Li FP, Strong LC Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990; 250:1233-1238 https://doi.org/10.1126/science.1978757
Chigurupati R, Alfatooni A, Myall RW Orofacial rhabdomyosarcoma in neonates and young children: a review of literature and management of four cases. Oral Oncol. 2002; 38:508-515 https://doi.org/10.1016/s1368-8375(01)00087-2
Wiss K, Solomon AR, Raimer SS Rhabdomyosarcoma presenting as a cutaneous nodule. Arch Dermatol. 1988; 124:1687-1690
Gawade PL, Hudson MM, Kaste SC A systematic review of dental late effects in survivors of childhood cancer. Pediatr Blood Cancer. 2014; 61:407-416 https://doi.org/10.1002/pbc.24842
Effinger KE, Migliorati CA, Hudson MM Oral and dental late effects in survivors of childhood cancer: a Children's Oncology Group report. Support Care Cancer. 2014; 22:2009-2019 https://doi.org/10.1007/s00520-014-2260-x
Najafi S, Tohidastakrad Z, Momenbeitollahi J. The long-term effects of chemo radiotherapy on oral health and dental development in childhood cancer. J Dent (Tehran). 2011; 8:39-43
Avsar A, Elli M, Darka O, Pinarli G. Long-term effects of chemotherapy on caries formation, dental development, and salivary factors in childhood cancer survivors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007; 104:781-789 https://doi.org/10.1016/j.tripleo.2007.02.029
Bohner L, Hanisch M, Kleinheinz J, Jung S. Dental implants in growing patients: a systematic review. Br J Oral Maxillofac Surg. 2019; 57:397-406 https://doi.org/10.1016/j.bjoms.2019.04.011

The Dental effects of head and neck rhabdomyosarcoma treatment: a case series

From Volume 49, Issue 8, September 2022 | Pages 639-644

Authors

Angharad Truman

BDS (Hons), MFDS, M Pros, FDS (Rest Dent) RCSEd, PGCME, FHEA

Specialty Registrar in Restorative Dentistry, Bristol Dental Hospital

Articles by Angharad Truman

Claire Forbes-Haley

BDS, MJDF RCS, FGDP UK, FDS Res Dent RCS

Consultant in Restorative Dentistry, School of Oral and Dental Sciences, Bristol Dental Hospital, Lower Maudlin Street, Bristol BS1 2LY, UK

Articles by Claire Forbes-Haley

Abstract

Rhabdomyosarcoma (RMS) is a malignant soft tissue neoplasm of skeletal muscle origin. Approximately 40% of cases of RMS are sited in the head and neck region and nearly 65% of cases are diagnosed in children less than six years of age. Treatment for RMS involves a multimodality approach including surgery, chemotherapy and radiotherapy. When children are exposed to such treatments there are often associated long-term adverse effect which may affect the patients' dento-alveolar growth and development. Three cases are described highlighting these adverse effects and the treatments used for oral rehabilitation.

CPD/Clinical Relevance: To inform readers of the long-term effects of rhabdomyosarcoma treatment on the dento-alveolar development.

Article

Rhabdomyosarcoma (RMS) is a malignant soft tissue neoplasm of skeletal muscle origin. It is reportedly the third most common extracranial solid tumour of childhood after Wilms' tumour and neuroblastoma.1,2,3,4 RMS is the most frequent soft tissue sarcoma encountered and accounts for approximately 6% of all malignancies in children under 15 years of age.3 Approximately 65% of cases are diagnosed in children younger than 6 years of age.2,5 There is a slight predilection for disease in males, with a male-to-female ratio of 1.3–1.5.2

The most common site for RMS, accounting for approximately 40% of cases, is the head and neck region.1 RMS of the head and neck are anatomically divided into two categories:

Register now to continue reading

Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Up to 2 free articles per month
  • New content available